We are live on ! Find out more
ACHN

Achillion Pharmaceuticals
ACHN

Delisted

ACHN was delisted on the 27th of January, 2020.

Back to rankings

161 hedge funds and large institutions have $770M invested in Achillion Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 48 increasing their positions, 34 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

256% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 18

219% more call options, than puts

Call options by funds: $125M | Put options by funds: $39.3M

41% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 34

40% more funds holding

Funds holding: 115 → 161 (+46)

23% more capital invested

Capital invested by funds: $627M → $770M (+$143M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
161
Holders Change
+46
Holders Change %
+40%
% of All Funds
4.67%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
64
Increased
48
Reduced
34
Closed
18
Calls
$125M
Puts
$39.3M
Net Calls
+$86M
Net Calls Change
+$29.7M

Top Buyers

Rank Fund Capital Flow
1
JHIU
Janus Henderson Investors US
Colorado
+$33.5M
2
Franklin Resources
Franklin Resources
California
+$25.6M
3
State Street
State Street
Massachusetts
+$11.6M
4
Goldman Sachs
Goldman Sachs
New York
+$8.81M
5
Millennium Management
Millennium Management
New York
+$8.68M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$147M
2
QF
QVT Financial
New York
-$45.3M
3
CCM
Camber Capital Management
Massachusetts
-$23.7M
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$7.78M
5
Morgan Stanley
Morgan Stanley
New York
-$7.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
HI
51
HBK Investments
Texas
$2.07M +$1.92M +207,100 New
AL
52
Airain Ltd
Guernsey
$2.06M +$1.81M +194,773 +1,745%
Morgan Stanley
53
Morgan Stanley
New York
$2.01M -$7.18M -773,848 -79%
BNP Paribas Asset Management
54
BNP Paribas Asset Management
France
$2.01M +$1.87M +201,614 New
U
55
UBS
Switzerland
$2.01M +$1.18M +127,235 +172%
RPAM
56
Rhenman & Partners Asset Management
Sweden
$2M -$1.21M -130,000 -39%
First Manhattan
57
First Manhattan
New York
$1.99M – – –
AllianceBernstein
58
AllianceBernstein
Tennessee
$1.91M – – –
OAM
59
Oxford Asset Management
United Kingdom
$1.81M +$1.67M +179,508 New
QBFM
60
QS Batterymarch Financial Management
New York
$1.8M +$1.67M +180,076 New
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$1.78M +$18.7K +2,014 +1%
PA
62
Perceptive Advisors
New York
$1.7M -$1.02M -110,000 -39%
Norges Bank
63
Norges Bank
Norway
$1.69M +$1.58M +169,731 New
Susquehanna International Group
64
Susquehanna International Group
Pennsylvania
$1.6M +$126K +13,522 +9%
RFC
65
Russell Frank Company
Washington
$1.59M +$1.48M +159,832 New
CCI
66
Columbus Circle Investors
$1.59M -$1.49M -160,574 -50%
O
67
OrbiMed
New York
$1.58M +$1.47M +158,000 New
BCM
68
Bridgeway Capital Management
Texas
$1.5M – – –
California Public Employees Retirement System
69
California Public Employees Retirement System
California
$1.18M – – –
D.E. Shaw & Co
70
D.E. Shaw & Co
New York
$1.12M +$310K +33,379 +43%
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
$1.08M +$15.6K +1,680 +2%
Ameriprise
72
Ameriprise
Minnesota
$1.06M +$989K +106,578 +71,052%
CS
73
Credit Suisse
Switzerland
$1.05M -$732K -78,880 -43%
JG
74
Jefferies Group
New York
$1.02M -$223K -24,037 -19%
CSS
75
Cubist Systematic Strategies
Connecticut
$957K +$640K +68,955 +256%
1 2
3
4 5

ACHN Hedge Fund Activity: Q3 2014 in Review

161 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Achillion Pharmaceuticals (ACHN) for Q3 2014, worth a combined $770M — up 23% from $627M a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new ACHN positions and 18 closed out — a net gain of 46 holders — while 48 added to existing stakes and 34 trimmed.

The largest buyer was Janus Henderson Investors US, opening a new position worth an estimated $33.5M. The largest seller was RA Capital Management, cutting an estimated $147M.

  • 161 institutional investors held Achillion Pharmaceuticals (ACHN) as of Q3 2014, up from 115 in Q2 2014.
  • Funds reported $770M of Achillion Pharmaceuticals stock for Q3 2014, up 23% quarter-over-quarter.
  • 64 funds opened new Achillion Pharmaceuticals positions in Q3 2014 and 18 closed out, a net change of +46 holders.
  • The largest Achillion Pharmaceuticals buyer in Q3 2014 was Janus Henderson Investors US, an estimated $33.5M added.
  • The largest Achillion Pharmaceuticals seller in Q3 2014 was RA Capital Management, an estimated $147M sold.

Based on aggregated 13F filings for Q3 2014.